Product Categories
Country: | China |
---|---|
Tel: | 021-59167510 |
Mobile: | 18117107507 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
BAY-218 | C20H17ClFN3O3 | 2162982-11-6 | Details |
RGX-104 | C34H33ClF3NO3 | 610318-54-2 | Details |
SPL-707 | C27H28FN5O4 | 2195361-33-0 | Details |
3'-Azido-3'-deoxy-5-fluorocytidine | C9H11FN6O4 | 2095417-18-6 | Details |
AZ2 | C20H23N3O2S | 2231760-33-9 | Details |
J-2156 TFA | 2387505-73-7 | Details |
TNF-α-IN-1 | C16H14ClN3O5 | 444287-49-4 | Details |
N6-Etheno 2'-deoxyadenosine | C12H13N5O3 | 68498-25-9 | Details |
NIK SMI1 | C20H19N3O4 | 1660114-31-7 | Details |
LDC7559 | C20H19N3O3 | 2407782-01-6 | Details |
CU-CPT-9a | C17H15NO2 | 2165340-32-7 | Details |
PF-06747711 | C26H26F3N5O2 | 1892576-58-7 | Details |
UCB9608 | C20H26N8O2 | 1616413-96-7 | Details |
H-151 | C17H17N3O | 941987-60-6 | Details |
VTX-27 | C20H24ClFN6O | 1321924-70-2 | Details |
C-176 | C11H7IN2O4 | 314054-00-7 | Details |
Olutasidenib | C18H15ClN4O2 | 1887014-12-1 | Details |
BCI hydrochloride | C22H24ClNO | 95130-23-7 | Details |
AS2717638 | C25H25N3O5 | 2148339-28-8 | Details |
TRPV4 agonist-1 free base | C25H22F2N4O2 | 2314467-59-7 | Details |
Patamostat | C20H20N4O4S | 114568-26-2 | Details |
BI-671800 | C25H26F3N5O3 | 1093108-50-9 | Details |
ML604440 | C17H24BF3N2O4 | 1140517-08-3 | Details |
Roflupram | C16H20F2O4 | 1093412-18-0 | Details |
(S)-Coriolic acid | C18H32O3 | 29623-28-7 | Details |
(αR,8aS)-GSK1614343 | C22H23F6N5O | 1092476-84-0 | Details |
Zetomipzomib maleate | C30H42N4O8.C4H4O4 | 2170983-62-5 | Details |
MLT-748 | C19H19Cl2N9O3 | 1832578-30-9 | Details |
Ly93 | C21H20N2O2 | 1883528-69-5 | Details |
diABZI STING agonist-1 trihydrochloride | C42H52ClN13O7 | 2138299-34-8 | Details |
L 888607 Racemate | C19H15ClFNO2S | 1030017-51-6 | Details |
GKT136901 | C19H15ClN4O2 | 955272-06-7 | Details |
YKL-05-099 | C32H34ClN7O3 | 1936529-65-5 | Details |
S1p receptor agonist 1 | C23H24FN3O3 | 1514888-56-2 | Details |
Brensocatib | C23 H24 N4 O4 | 1802148-05-5 | Details |
CA-170 | C12H20N6O7 | 1673534-76-3 | Details |
Pexacerfont | C18H24N6O | 459856-18-9 | Details |
PF-4878691 | C17H23N5O2S | 532959-63-0 | Details |
Etomoxir | C17H23ClO4 | 124083-20-1 | Details |
Manitimus | C15H11F3N2O2 | 202057-76-9 | Details |
RIPA-56 | C13H19NO2 | 1956370-21-0 | Details |
Tazanolast | C13H15N5O3 | 82989-25-1 | Details |
EMD527040 | C29H32Cl2N4O5 | 851333-14-7 | Details |
Naltriben mesylate | C27H29NO7S | 122517-78-6 | Details |
SPD304 dihydrochloride | C32H33ClF3N3O2 | 1049741-03-8 | Details |
SOCE inhibitor 1 | C25H22F3N5O4 | 2169316-15-6 | Details |
CP 376395 | C21H30N2O | 175140-00-8 | Details |
PKA-IN-1 | C13H11N3O | 179985-52-5 | Details |
SB-747651A dihydrochloride | C16H23ClN8O | 1781882-72-1 | Details |
Verucerfont | C22H26N6O2 | 885220-61-1 | Details |
NOD-IN-1 | C18H17NO4S | 132819-92-2 | Details |
Icerguastat | C8H9ClN4 | 951441-04-6 | Details |
Zegocractin | C19H11ClF3N3O3 | 1713240-67-5 | Details |
SPR inhibitor 3 | C14H18N2O3 | 1292285-54-1 | Details |
BMS-470539 dihydrochloride | C32H42ClN5O4 | 2341796-82-3 | Details |
CRAC intermediate 2 | C11H7F6N3 | 123066-64-8 | Details |
Trimethylamine N-oxide-d9 | C3D9NO | 1161070-49-0 | Details |
(S)-Flurbiprofen | C15H13FO2 | 51543-39-6 | Details |
GSK3179106 | C22H21F4N3O4 | 1627856-64-7 | Details |
Synta66 | C20H17FN2O3 | 835904-51-3 | Details |
PAP-1 | C21H18O5 | 870653-45-5 | Details |
Paquinimod | C21H22N2O3 | 248282-01-1 | Details |
GSK-872 | C19H17N3O2S2 | 1346546-69-7 | Details |
LY2955303 | C36H42N4O3 | 1433497-19-8 | Details |
PF-4191834 | C22H23N3O2S | 1029317-21-2 | Details |
APX-115 | C17H18ClN3O | 1395946-75-4 | Details |
Razuprotafib | C26H26N4O6S3 | 1008510-37-9 | Details |
L-Valyl-L-phenylalanine | C14H20N2O3 | 3918-92-1 | Details |
Furprofen | C14H12O4 | 66318-17-0 | Details |
Raleukin | C20H23N5O7S2 | 143090-92-0 | Details |
L-NIL | C8H17N3O2 | 53774-63-3 | Details |
N6,N6-Dimethyladenosine | C12H17N5O4 | 2620-62-4 | Details |
PF-03654764 | C20H28F2N2O | 935840-35-0 | Details |
Obafistat | C15H16FN5O3S | 2160582-57-8 | Details |
PS10 | C14H13NO6S | 1564265-82-2 | Details |
TMP778 | C31H30N2O4 | 1422053-04-0 | Details |
IHVR-11029 | C18H27F2NO5 | 1383152-30-4 | Details |
c-di-AMP disodium | C20H25N10NaO12P2 | 2734909-87-4 | Details |
ARN 077 | C16H21NO4 | 1373625-34-3 | Details |
Ablukast | C28H34O8 | 96566-25-5 | Details |
C-178 | C17H10N2O5 | 329198-87-0 | Details |
ZCZ011 | C21H18N2O2S | 1998197-39-9 | Details |
Avelumab | 1537032-82-8 | Details |
RU-301 | C21H19F3N4O4S | 1110873-99-8 | Details |
Linzagolix | C22H15F3N2O7S | 935283-04-8 | Details |
PI3Kδ-IN-1 | C22H20F3N7O2 | 1911564-39-0 | Details |
Eliapixant | C22H21F3N4O3S | 1948229-21-7 | Details |
N6-(2-Phenylethyl)adenosine | C18H21N5O4 | 20125-39-7 | Details |
A-770041 | C34H39N9O3 | 869748-10-7 | Details |
INF4E | C12H13ClO3 | 88039-46-7 | Details |
TH1020 | C23H15N7S2 | 1841460-82-9 | Details |
JNJ-55308942 | C17H12F5N7O | 2166558-11-6 | Details |
Labetalol | C19H24N2O3 | 36894-69-6 | Details |
Ensifentrine | C26H31N5O4 | 1884461-72-6 | Details |
TLR7 agonist 2 | C17H16N6O2 | 1642857-69-9 | Details |
TC-S 7005 | C21H17N3O3 | 1082739-92-1 | Details |
GSK 366 | C17H16ClN3O4 | 1953157-39-5 | Details |
S18-000003 | C26H25F3N2O4S | 2068119-11-7 | Details |
UNC0379 | C23H35N5O2 | 1620401-82-2 | Details |
TAK1-IN-4 | C18H17N3O3 | 1570374-32-1 | Details |
Product Total: Product Page: | ||||
7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 |